Navigation Links
Health Robotics Announces IV Station (TM Pending) a Centrally-Controlled,
Date:6/7/2008

Modular, Distributed, Flexible, Redundant, Patient-Specific Intra-Venous (IV) Automation Robot for Non-Hazardous Drug Preparation, Compounding, and Dispensing in Central Pharmacy Locations, Satellite Pharmacies, and Even

Patient Care Workplaces

BOZEN, SUDTIROL, Italy, June 7 /PRNewswire/ -- Health Robotics, the worldwide leader in the robotic automation of patient-specific IV Admixtures today announced IV Station (TM Pending), a new IV automation solution that complements CytoCare(TM), the company's award-winning and world-leading patient-specific chemotherapy IV robot.

IV Station (TM Pending) is aimed at helping global health care providers deliver rapid, cost-effective, and safer IV doses to their patients by addressing medication errors, sterility, accuracy, and waste problems in the preparation, compounding, and dispensing of IV Admixtures.

"While many companies have recognized the life-critical importance of IV safety, all patient-specific automation solutions up until now have focused on the prescription and administration steps of the medication delivery process with products such as Electronic Prescription and Smart Infusion Pumps," said Werner Rainer, CEO of Health Robotics.

IV Station (TM Pending) is the first patient-specific automation solution in the world that focuses on the preparation and compounding step of the life-critical process of IV Admixtures, where medication errors are arguably more critical given the inherent difficulty in their detection.

Beyond its patient safety benefits, IV Station (TM Pending) will address the waste problems of the current pharmacy process of Batch IVs [IVs that are not tailored to a specific patient clinical condition and therapy], whether these Batch IVs are processed by Batch IV automation companies or by hospitals that compound manually in Batch mode. IV Station (TM Pending) offers global health care providers unique features and benefits by pi
'/>"/>

SOURCE Health Robotics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Leiner Health Products Issues Allergy Alert on Undeclared Allergens in Liquimax(R) Multivitamin
2. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
3. Grubb & Ellis Healthcare REIT Acquires Nutfield Professional Center in Derry, N.H.
4. World Medical Tourism & Global Health Congress Connects Global Healthcare Providers with Global Insurance Companies
5. Service Employee Unions Latest Attack on RNs Parrots McCains Attack on Obamas Health Plan
6. UNC to study link between sustainable farming and health
7. Universal Health Realty Income Trust Announces Dividend Increase
8. Kagomes Yellow Mango Orchard Blended Juice Named One of Americas Healthiest Buys
9. Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans
10. Rite Aid Health and Beauty Expo to Showcase GNC Athletes
11. Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... By discovering a new mechanism that allows blood ... at UC Irvine and the Salk Institute have opened ... prevent stroke-induced brain damage. , A complex and devastating ... and primary reason for disability in the U.S. The ... lets blood-borne material into the brain, causing the permanent ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
(Date:4/17/2014)... Spending time online has the potential to ward off ... according to research published online in The ... Sciences . In the article " Internet Use ... States: A Longitudinal Analysis ," the authors report that ... by 33 percent among their study sample. , ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... 17, 2014 Meaningful long-term survival is possible ... the abdomen when treated with cytoreductive surgery with ... first-of-its-size analysis by physicians at Wake Forest Baptist ... largest reported, single-center experience with cytoreductive surgery and ... and analysis of 20 years, worth of patient ...
Breaking Medicine News(10 mins):Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... homeless population among New Yorkers are more prone to go ... the population. // Detox centers will be established at some ... on the rise. Rapid HIV testing for women who are ... the Health Department. ,A large number of ...
... Copeman Healthcare of Canada has been warned of fines by ... insured health services. Copeman Healthcare intends to establish clinics in ... it will be charging a joining fee of $1,200, and ... ,The medicare law of the state says ...
... worst hit by AIDS. But now after bringing in changes in ... the initial sex // and using condoms have greatly reduced the ... ,It was found that among women in the age group of ... was witnessed among men in the age group of 17-29. ...
... model has been developed that can predict the occurrence of ... mild or severe can be told five months before it ... emergency measures to be done in advance. ,The ... officials these days. ,The problem is greatest ...
... by a House of Lords committee has revealed that 90 ... tested on them. Dangerous drugs like morphine, // thyrozine, the ... the treatment of children even though there was no valid ... ,The report also alleges that some high-risk medications like asthma ...
... recruit 50,000 people as a part of a large study called ... between lifestyle and genetics as regards the health of an individual. ... and is one of the largest healthcare projects in the UK. ... of information so that it would be easy to assess who ...
Cached Medicine News:Health News:Prediction of malaria epidemics possible! 2
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
(Date:1/15/2014)... Pharmaceuticals International, Inc. (NYSE: VRX and ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with ... indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all ... Medical, Inc. (NASDAQ: SLTM ) ("Solta") at ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... K-V Pharmaceutical Company (NYSE:  KVa/KVb) (the "Company") today announced that ... U.S. Healthcare II, L.L.C. (together the "Lenders") that grant Lenders ... Company,s Class A Common Stock, par value $.01 per share ... second warrant to Lenders that grants Lenders the right to ...
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... diagnostic ("IVD") company, today announced its unaudited financial results ... ("2Q FY2010"). 2Q FY20 10 ... increased by 21.5% year-over-year to RMB201.8 million (US$30.2 million). ...
Cached Medicine Technology:K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 2K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 3K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 4K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 5K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 6K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 7K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 8K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 9K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSE's Shareholder Approval Policy 10China Medical Technologies Reports Second Fiscal Quarter Financial Results 2China Medical Technologies Reports Second Fiscal Quarter Financial Results 3China Medical Technologies Reports Second Fiscal Quarter Financial Results 4China Medical Technologies Reports Second Fiscal Quarter Financial Results 5China Medical Technologies Reports Second Fiscal Quarter Financial Results 6China Medical Technologies Reports Second Fiscal Quarter Financial Results 7China Medical Technologies Reports Second Fiscal Quarter Financial Results 8China Medical Technologies Reports Second Fiscal Quarter Financial Results 9China Medical Technologies Reports Second Fiscal Quarter Financial Results 10China Medical Technologies Reports Second Fiscal Quarter Financial Results 11China Medical Technologies Reports Second Fiscal Quarter Financial Results 12China Medical Technologies Reports Second Fiscal Quarter Financial Results 13China Medical Technologies Reports Second Fiscal Quarter Financial Results 14
... Volk's super series ... lenses. Variable retinal ... unprecedented fundus diagnostic ... maximum potential field ...
Volk indirect lenses. Wide field retinal diagnosis & treatment....
Volk indirect lenses. High magnification views of the posterior pole....
... This contact class is particularly ... lamps which have a smaller ... the reduction prism than the ... fundus / iridocornea. Mirror angle ...
Medicine Products: